Decreases in circulating concentrations of short-chain acylcarnitines are associated with systolic function improvement after decompensated heart failure

Wei Siang Chen, Min Hui Liu, Mei Ling Cheng, Chao Hung Wang*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

9 Scopus citations

Abstract

Impaired fatty acid metabolism is associated with heart failure (HF) prognosis. However, specific changes in acylcarnitine profiles and their potential clinical value have not been well explored in patients recovering from acute decompensation. This study recruited 79 HF patients hospitalized because of acute decompensation with a left ventricular ejection fraction (LVEF) of < 40% and 51 normal controls. Patients were dichotomized into two groups, namely, the “improved (IMP)” and the “non-improved (NIMP)” groups, as defined by the changes in LVEF from baseline to 12 months after discharge. Mass spectrometry was used to quantify the acylcarnitine concentrations at baseline and 6 and 12 months after discharge. The IMP and NIMP groups contained 42 and 37 pa-tients, respectively. At baseline, HF patients had higher plasma concentrations of specific long-, medium-, and short-chain acylcarnitines compared to normal controls. From baseline to 12 months post-discharge, the IMP group showed significant decreases in long-and short-chain acylcarnitine concentrations, but significant increases in medium-chain acylcarnitines. In the NIMP group, none of the acylcarnitines significantly decreased, and significant increases were noted in long-, medium-, and short-chain acylcarnitines. Generalized estimating equations demonstrated that nine acylcarnitines could discriminate the IMP group from the NIMP group, including three long-chain (C18:1, C16, and C16:1) and six short-chain acylcarnitines (C5, C5-OH, C4, C4:1-DC, C3, and C2). After adjusting for age, the six short-chain acylcarnitines remained significant. Changes in short-chain acylcarnitine profiles are independently associated with the improvement in cardiac systolic function after acute decompensation.

Original languageEnglish
Pages (from-to)1014-1021
Number of pages8
JournalInternational Heart Journal
Volume61
Issue number5
DOIs
StatePublished - 2020

Bibliographical note

Publisher Copyright:
© 2020, International Heart Journal Association. All rights reserved.

Keywords

  • Fatty acid
  • Lipidomics
  • Metabolism

Fingerprint

Dive into the research topics of 'Decreases in circulating concentrations of short-chain acylcarnitines are associated with systolic function improvement after decompensated heart failure'. Together they form a unique fingerprint.

Cite this